Through comparison of variants identified in the patient's cells with the CGC database, we identified potential cancer susceptibility genes: NUTM1 and PTPRD. NUTM1 has a strong association with Nut midline carcinoma, a newly identified, rare, and highly aggressive squamous cell carcinoma characterized by extremely low survival rates [9]. Here, PTPRD is linked to squamous cell carcinoma.